|
 |
VICH Guidelines by Category |
|
|
| Pre-approval |
|
|
|
|
| |
General |
|
|
GL9 |
| |
Biologicals |
|
|
|
| |
|
Quality |
|
GLs 34, 25 & 26 |
| |
|
Safety |
|
|
| |
|
|
TAS |
GLs 41 & 44 |
| |
Pharmaceuticals |
Quality |
|
GLs 1, 2, 3, 4, 5, 8, 10, 11, 17,
18, 39, 40,
45 |
| |
|
Efficacy |
|
|
| |
|
|
Anthelmintics |
GLs 7, 12, 13, 14, 15, 16, 19, 20 & 21 |
| |
|
Safety |
|
|
| |
|
|
Environmental Safety |
GLs 6 & 38 |
| |
|
|
Metabolism
and Residue |
GLs 46,
47, 48,
49 |
| |
|
|
Toxicology |
GLs 22, 23, 28, 31, 32,
33 & 37 |
| |
|
|
Target Animal Safety |
GL 43 |
| |
|
|
Antimicrobial Safety |
GLs 27 & 36 |
| Post-approval |
|
|
|
|
| |
Pharmacovigilance |
|
|
GLs 24, 29, 30, 35 & 42 |
|
|
|
